ABSTRACT
Whether or not risk compensation could offset the preventive effect of early antiretroviral therapy (ART) on heterosexual HIV transmission remains unknown. Using virological and behavioral data collected 12 months after inclusion in the TEMPRANO-ANRS12136 randomized controlled trial of early ART (Abidjan, Côte d'Ivoire), we estimated the risk of HIV transmission and compared it between the intervention (early ART, n=490) and control (deferred ART, n=467) groups. We then simulated increases in various sexual risk behaviors in the intervention group and estimated the resulting preventive effect.
Based on reported values of sexual behaviors, we estimated an 89% (95% Confidence Interval: 81%, 95%) preventive effect of early ART on the cumulative HIV transmission risk over a one-month period.
This preventive effect remained significant for a wide range of parameters combinations and was offset (ie non-significant) only for dramatic increases simulated simultaneously in different sexual behaviors.
For example, when considering a two-fold increase in serodiscordance and the frequency of sexual intercourse together with a 33% decrease in condom use, the resulting preventive effect was 47% (95%CI: -3%, 74%). An important reduction of HIV transmission in the short-term may thus be expected from the scale-up of early ART, even in the context of behavioral change. 
(Main text word count: 1967 words)
Early antiretroviral therapy (ART) is a promising strategy to curb the HIV/AIDS epidemic, especially in sub-Saharan Africa. Through its effect on HIV replication, early ART reduces the risk of HIV transmission to uninfected sexual partners (1). However, it remains unclear as to whether risk compensation-an increase in sexual risk behaviors resulting from a decrease in the perceived risk of transmission-could result from expanded use of ART and whether or not it could offset its preventive effect.
Changes in risk behaviors have been suggested to explain limited decreases in HIV incidence associated with ART expansion in various settings (2, 3) . However, numerous studies including a metaanalysis have reported a decrease in sexual risk behaviors after ART initiation in patients with low CD4 count or advanced HIV disease (4) (5) (6) . Few studies have assessed behavioral changes in healthier heterosexual individuals initiating ART earlier. A recent study nested in the TEMPRANO-ANRS12136 early ART randomized controlled trial has documented no effect of early ART initiation on sexual behaviors as compared to pre-2015 WHO-guided ART initiation (7) . Nevertheless, generalizability of these results may be limited by the fact that they were obtained in a trial context in which the treatment was proposed to the participants for their own benefits, without any information on its potential preventive benefit.
In the absence of clear experimental evidence for risk compensation associated with early ART, we used computer simulations relying on individual data collected within the TEMPRANO-ANRS12136 trial with a previously developed methodology (8) to assess the levels of increase in sexual risk behaviors that would be needed to offset the preventive benefit of early ART 12 months after initiation. At 12 months, 82.9% of the participants in the early ART group had achieved virological control (detectability threshold: 300 copies/mL) versus 10.5% in the deferred ART group (all of these participants with undetectable VL having initiated ART according to current guidelines; χ², P<0.0001).
In the early ART group, 30.2% of the participants had their most recent sexual intercourse in the past month with a serodiscordant partner (deferred ART: 32.5 %; χ², P = 0.43) and 66.9 % reported having used a condom (deferred ART: 60.5 %; χ², P = 0.25) (8).
Base case: estimating the preventive effect of early ART Partners with unknown HIV status were considered HIV uninfected. Transmission risk was set to zero in case of undetectable VL (ie <300 cp/µL) (11, 12) . The risk of transmission was estimated at last sexual intercourse ( = 1) or cumulated over a one-month period, assuming a mean monthly number of eight sexual intercourses (13, 14) .
Individual risks of HIV transmission ( ) were averaged among participants from each ART group (Figure 1 , Equations 2.1 and 2.2) to estimate the preventive effect of early ART (Figure 1, Equation 3 ).
Varying the effect of risk compensation associated with early ART
To explore the potential impact of risk compensation associated with early ART, we varied the levels of serodiscordant sexual activity and condom use among the early ART group only and estimated the resulting average risk that we compared to the observed average risk of the deferred ART group ( Figure   1 ).
To vary the group-level expected value of serodiscordant sexual activity : i) we generated different
Bernoulli distributions with probabilities between 10% and 100%; ii) for each distribution we randomly selected individual values and then estimated individual using Equation 1 ( Figure 1) ; iii) we computed and estimated the preventive effect of early ART by dividing by the observed average risk , obtained among the deferred ART group in the base case (ie with observed values) ; iv) we computed 95% confidence intervals for preventive effect estimates using bootstrap resampling (2,000 samples). We repeated the above steps while varying the expected value of condom use instead of , and finally while varying both parameters simultaneously. We also considered an additional scenario where we simultaneously varied these parameters and stimulated a two-fold increase in the monthly frequency of sexual intercourse in the early ART group. Note that when considering the risk of transmission cumulatively over a one-month period, we extrapolated the condom use reported for the most recent intercourse to all intercourses assumed over this period.
Analyses were performed using R software v2.15.1. example, for 60% serodiscordance and 40% condom use, the preventive effect was 47% (-3%, 74%).
RESULTS

Base case and univariate variations
In the worst-case scenario, the central value of early ART preventive effect was negative, though non-
DISCUSSION
This study showed that a phenomenon of risk compensation -if it exists -should reach quite unrealistic levels to offset the short term preventive benefits of early ART compared with deferred ART initiation.
Our model predicts that such an offset should occur only in the event of a simultaneous and substantial increase in several key sexual behaviors: a two-fold increase in the frequency of sexual intercourse and serodiscordance (60% versus 32.5% for deferred ART) and a 33% decrease in condom use (40% versus 60.5% for deferred ART).
By reducing the VL of the HIV-infected persons to an undetectable level, ART may theoretically prevent HIV transmissions (11, 12, 15) . In the TEMPRANO trial, more than 4 out of every 5 treated patients in the early ART group achieved viral suppression 12 months after ART initiation. In that case, if behavioral change occurs, it may result in an increased risk of transmission only among the approximately 20% of participants who did not achieve viral suppression. This explains the magnitude of our estimated preventive effect of early ART even at high levels of risk compensation. This preventive effect is likely to remain high in the long term under conditions of high levels of retention in care and adherence to treatment.
Significant increases in sexual risk behaviors related to ART have been documented previously.
However, such increases were mostly observed among individuals from high-risk groups who were initially deeply immunocompromised, for whom ART allowed health recovery and the possible return to sexual activity (16, 17) . Comparable increases in sexual risk behaviors in patients at an early stage of HIV infection are less likely. Moreover, more recent results suggest that early entry into HIV care, with or without ART initiation, may be followed by a decrease in sexual risk behaviors (7).
Our results were obtained from a population of patients recruited in nine different clinical centers where all eligible patients were systematically approached. The quite low refusal rate (16%) suggests a limited selection bias. The sex ratio favoring women may reflect the national context of higher HIV prevalence and higher opportunities for early diagnoses for women compared to men (18) . The proportion of viral suppression achieved in participants receiving early ART 12 months after enrolment (83%) was not dramatically higher than that documented in population-based studies throughout sub-Saharan Africa (19) . Together, all the elements above are in favor of the generalizability of our findings outside the setting of a clinical trial.
Our study has several limitations. We explored the potential impact of risk compensation based on VL measured 12 months after early ART initiation. Risk compensation may have a higher mitigating impact on ART preventive effect if occurring in the first months following ART initiation, before VL suppression is achieved (20) . We accounted for the last sexual partner only and estimated the risk of HIV transmission over a number of sexual intercourses corresponding to a relatively short time period.
Nevertheless, extrapolating over a longer time period or to several sexual partners may have led to potentially unreliable results. Our estimates assume that risk compensation occurs similarly among adherent and non-adherent patients. However, patients being prescribed ART without actually using it could be less likely to perceive a reduced risk of HIV transmission and, consequently, to engage in risk compensation. This may have led to an overestimation of the detrimental effect of risk compensation on early ART preventive benefits.
The concern of risk compensation has been raised for almost every innovation in HIV prevention (21).
However, results have shown that this phenomenon can be prevented by offering interventions in combination with traditional prevention methods (such as counselling or condom promotion) (22, 23) .
Our results suggest that even if risk compensation occurred among HIV-positive patients on early ART, it would unlikely be able to counter-balance its preventive benefit. A dramatic reduction of HIV transmission might be actually expected from the scaling up of early ART even in the context of behavioral change. However, the promotion of sexual health remains a priority to alleviate the burden of sexually transmitted diseases and other sex-related risks.
